Insulet Corp. closed $9.41 below its 52-week high ($279.77), which the company achieved on December 12th.

Insulet Corporation ( NASDAQ:PODD ) saw a double-digit share price rise of over 10% in the past couple of months on ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of ...

Shares of Insulet Corp. PODD shed 1.03% to $265.65 Tuesday, on what proved to be an all-around grim trading session for the ...

Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Buying $100 In PODD: If an investor had bought $100 of PODD stock 10 years ago, it would be worth $598.02 today based on a ...

In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Insulet (PODD – Research Report), with a price target of ...

Intuitive Surgical (ISRG), and Insulet (PODD) stocks were cited as top MedTech stock picks for 2025 by J.P. Morgan. Read more ...

Bernstein raised the firm’s price target on Insulet (PODD) to $315 from $305 and keeps an Outperform rating on the shares as part of a broader ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. While Beta Bionics ...